BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1594556)

  • 1. Gastrin-releasing peptide: binding and functional studies in mouse pancreatic islets.
    Wahl MA; Landsbeck EA; Ammon HP; Verspohl EJ
    Pancreas; 1992; 7(3):345-51. PubMed ID: 1594556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanisms by which gastrin releasing peptide potentiates glucose-induced insulin secretion from mouse islets.
    Gregersen S; Ahrén B
    Pancreas; 1996 Jan; 12(1):48-57. PubMed ID: 8927619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of gastrin-releasing peptide (GRP) receptors in insulin secreting cells.
    Kloss H; Wahl MA; Neye H; Verspohl EJ
    Cell Biochem Funct; 1999 Dec; 17(4):229-36. PubMed ID: 10587610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrin releasing peptide augments glucose mediated 45Ca2+ uptake, electrical activity, and insulin secretion of mouse pancreatic islets.
    Wahl MA; Plehn RJ; Landsbeck EA; Verspohl EJ; Ammon HP
    Endocrinology; 1991 Jun; 128(6):3247-52. PubMed ID: 2036987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gastrin-releasing peptide on the secretion of mouse islet hormones in vitro.
    Wilkes LC; Bailey CJ; Thompson MG; Conlon JM; Buchanan KD
    J Endocrinol; 1990 Nov; 127(2):335-40. PubMed ID: 2250156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin secretion by gastrin-releasing peptide in mice: ganglionic versus direct islet effect.
    Karlsson S; Sundler F; Ahrén B
    Am J Physiol; 1998 Jan; 274(1):E124-9. PubMed ID: 9458757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans.
    Verspohl EJ; Ammon HP; Williams JA; Goldfine ID
    Diabetes; 1986 Jan; 35(1):38-43. PubMed ID: 3000856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine.
    Doliba NM; Qin W; Vatamaniuk MZ; Li C; Zelent D; Najafi H; Buettger CW; Collins HW; Carr RD; Magnuson MA; Matschinsky FM
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E834-43. PubMed ID: 14736703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activin A: its effects on rat pancreatic islets and the mechanism of action involved.
    Verspohl EJ; Ammon HP; Wahl MA
    Life Sci; 1993; 53(13):1069-78. PubMed ID: 8366769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct cytoplasmic CA(2+) responses to gastrin-releasing peptide in single beta cells.
    Karlsson S; Sundler F; Ahrén B
    Biochem Biophys Res Commun; 2001 Jan; 280(3):610-4. PubMed ID: 11162563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
    Narayan S; Guo YS; Townsend CM; Singh P
    Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal polypeptide-augmented insulin release: actions on ionic fluxes and electrical activity of mouse islets.
    Wahl MA; Straub SG; Ammon HP
    Diabetologia; 1993 Oct; 36(10):920-5. PubMed ID: 8243870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells.
    Frucht H; Gazdar AF; Park JA; Oie H; Jensen RT
    Cancer Res; 1992 Mar; 52(5):1114-22. PubMed ID: 1310640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of neuromedin B and neuromedin C on exocrine and endocrine rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Tani S; Oka T; Yajima H; Baba S
    Am J Physiol; 1987 Apr; 252(4 Pt 1):G491-8. PubMed ID: 2436486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and stimulation by gastrin-releasing peptide of protein kinase C subfamilies in insulin-secreting cells.
    Bihlmayer A; Ammon HP; Wahl MA
    Neuroendocrinology; 2001 May; 73(5):352-7. PubMed ID: 11399908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35.
    Gregersen S; Lindskog S; Land T; Langel U; Bartfai T; Ahrén B
    Eur J Pharmacol; 1993 Feb; 232(1):35-9. PubMed ID: 7681407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of galanin in human pancreatic nerves and inhibition of insulin secretion from isolated human islets.
    Ahrén B; Ar'Rajab A; Böttcher G; Sundler F; Dunning BE
    Cell Tissue Res; 1991 May; 264(2):263-7. PubMed ID: 1715240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of gastrin-releasing peptide on the endocrine pancreas.
    McDonald TJ; Houghton P; Challis JR; Hramiak IM
    Ann N Y Acad Sci; 1988; 547():242-54. PubMed ID: 3071222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P, neurokinin A, vasoactive intestinal polypeptide and gastrin releasing peptide in the intestine and pancreas of spontaneously obese-diabetic mice.
    Bailey CJ; Flatt PR; Deacon CF; Shaw C; Conlon JM
    Regul Pept; 1986 Dec; 16(3-4):339-48. PubMed ID: 2436255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of insulin release by galanin and gastrin-releasing peptide in the anaesthetized rat.
    Schnuerer EM; McDonald TJ; Dupre J
    Regul Pept; 1987 Sep; 18(5-6):307-20. PubMed ID: 2445005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.